Fresenius Medical Care AG & Co. KGaA Statistics
Share Statistics
Fresenius Medical Care AG & Co. KGaA has 586.83M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 586.83M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 586.39M |
Failed to Deliver (FTD) Shares | 239 |
FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 730.18K, so 0.12% of the outstanding shares have been sold short.
Short Interest | 730.18K |
Short % of Shares Out | 0.12% |
Short % of Float | 0.12% |
Short Ratio (days to cover) | 3.75 |
Valuation Ratios
The PE ratio is 11.3 and the forward PE ratio is 8.1. Fresenius Medical Care AG & Co. KGaA's PEG ratio is 0.38.
PE Ratio | 11.3 |
Forward PE | 8.1 |
PS Ratio | 0.29 |
Forward PS | 0.6 |
PB Ratio | 0.41 |
P/FCF Ratio | 2.9 |
PEG Ratio | 0.38 |
Enterprise Valuation
Fresenius Medical Care AG & Co. KGaA has an Enterprise Value (EV) of 16.29B.
EV / Earnings | 32.64 |
EV / Sales | 0.84 |
EV / EBITDA | 5.07 |
EV / EBIT | 11.89 |
EV / FCF | 8.38 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.58.
Current Ratio | 1.42 |
Quick Ratio | 1.07 |
Debt / Equity | 0.58 |
Total Debt / Capitalization | 36.72 |
Cash Flow / Debt | 0.33 |
Interest Coverage | 3.22 |
Financial Efficiency
Return on equity (ROE) is 0.04% and return on capital (ROIC) is 3.61%.
Return on Equity (ROE) | 0.04% |
Return on Assets (ROA) | 0.01% |
Return on Capital (ROIC) | 3.61% |
Revenue Per Employee | 172.04K |
Profits Per Employee | 4.41K |
Employee Count | 113.08K |
Asset Turnover | 0.57 |
Inventory Turnover | 6.67 |
Taxes
Income Tax | 300.56M |
Effective Tax Rate | 0.29 |
Stock Price Statistics
The stock price has increased by 14.6% in the last 52 weeks. The beta is 0.85, so Fresenius Medical Care AG & Co. KGaA's price volatility has been higher than the market average.
Beta | 0.85 |
52-Week Price Change | 14.6% |
50-Day Moving Average | 21.42 |
200-Day Moving Average | 20.34 |
Relative Strength Index (RSI) | 65.12 |
Average Volume (20 Days) | 255.46K |
Income Statement
In the last 12 months, Fresenius Medical Care AG & Co. KGaA had revenue of $19.45B and earned $499.00M in profits. Earnings per share was $1.7.
Revenue | 19.45B |
Gross Profit | 4.93B |
Operating Income | 1.37B |
Net Income | 499.00M |
EBITDA | 3.21B |
EBIT | 1.37B |
Earnings Per Share (EPS) | 1.7 |
Balance Sheet
The company has $1.40B in cash and $12.05B in debt, giving a net cash position of -$10.65B.
Cash & Cash Equivalents | 1.40B |
Total Debt | 12.05B |
Net Cash | -10.65B |
Retained Earnings | 10.92B |
Total Assets | 32.51B |
Working Capital | 2.20B |
Cash Flow
In the last 12 months, operating cash flow was $2.63B and capital expenditures -$684.60M, giving a free cash flow of $1.94B.
Operating Cash Flow | 2.63B |
Capital Expenditures | -684.60M |
Free Cash Flow | 1.94B |
FCF Per Share | 6.63 |
Margins
Gross margin is 25.32%, with operating and profit margins of 7.04% and 2.57%.
Gross Margin | 25.32% |
Operating Margin | 7.04% |
Pretax Margin | 5.31% |
Profit Margin | 2.57% |
EBITDA Margin | 16.5% |
EBIT Margin | 7.04% |
FCF Margin | 9.99% |
Dividends & Yields
FMS pays an annual dividend of $0.63, which amounts to a dividend yield of 2.66%.
Dividend Per Share | $0.63 |
Dividend Yield | 2.66% |
Dividend Growth (YoY) | 1.93% |
Payout Ratio | 53.39% |
Earnings Yield | 7.19% |
FCF Yield | 14.02% |
Analyst Forecast
The average price target for FMS is $23, which is -2.7% lower than the current price. The consensus rating is "Hold".
Price Target | $23 |
Price Target Difference | -2.7% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Stock Splits
The last stock split was on Dec 4, 2012. It was a forward split with a ratio of 2:1.
Last Split Date | Dec 4, 2012 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 1.79 |
Piotroski F-Score | 8 |